郑州微飒生物科技有限责任公司 咨询热线:0371-88821766
行业动态

行业动态

追踪行业前沿,洞察产业趋势

药效评价A novel recombinant, VPAC2-selective agonist enhancing insulin release and glucose disposal.

期刊:Acta pharmacologica Sinica发表年份:2007作者:Rong-jie Yu; Ngai-lik Tam; Yuan Gao; Zhi-hong Zeng; Tian-hong Zhou; An Hong

药效评价Development of orally bioavailable and CNS penetrant biphenylaminocyclopropane carboxamide bradykinin B1 receptor antagonists.

期刊:Journal of medicinal chemistry发表年份:2007作者:Scott D Kuduk; Christina N Di Marco; Ronald K Chang; Michael R Wood; Kathy M Schirripa; June J Kim; Jenny M C Wai; Robert M DiPardo; Kathy L Murphy; Richard W Ransom; C Meacham Harrell; Duane R Reiss; Marie A Holahan; Jacquelynn Cook; J Fred Hess; No

药效评价Differential intracellular signaling through PAC1 isoforms as a result of alternative splicing in the first extracellular domain and the third intracellular loop.

期刊:Molecular pharmacology发表年份:2007作者:Mina Ushiyama; Ryuji Ikeda; Hideki Sugawara; Morikatsu Yoshida; Kenji Mori; Kenji Kangawa; Kazuhiko Inoue; Katsushi Yamada; Atsuro Miyata

药效评价Pharmacological and physiological characterization of d[Leu4, Lys8]vasopressin, the first V1b-selective agonist for rat vasopressin/oxytocin receptors.

期刊:Endocrinology发表年份:2007作者:Ana Pena; Brigitte Murat; Miguel Trueba; Maria A Ventura; Gyslaine Bertrand; Ling Ling Cheng; Stoytcho Stoev; Hazel H Szeto; Nga Wo; Gabrielle Brossard; Claudine Serradeil-Le Gal; Maurice Manning; Gilles Guillon